epitopebas
vaccin
provid
new
strategi
prophylact
therapeut
applic
pathogenspecif
immun
critic
requir
strategi
identif
select
tcell
epitop
act
vaccin
target
studi
describ
current
methodolog
select
process
dengu
viru
model
system
combin
publicli
avail
bioinformat
algorithm
comput
tool
use
screen
select
antigen
sequenc
potenti
tcell
epitop
supertyp
hla
allel
select
sequenc
test
biolog
function
activ
tcell
hla
transgen
mice
pathogen
infect
subject
approach
provid
experiment
basi
design
pathogen
specif
tcell
epitopebas
vaccin
target
major
genet
variant
pathogen
effect
broad
rang
differ
human
leukocyt
antigen
among
global
human
popul
new
develop
immunoinformat
comput
methodolog
combin
broad
versatil
design
synthesi
genet
dna
vaccin
underlay
new
strategi
novel
design
antigenspecif
epitopebas
vaccin
mani
pathogen
current
proven
refract
convent
vaccin
therapi
earli
clinic
trial
epitopebas
vaccin
human
immunodefici
viru
hiv
malaria
tuberculosi
produc
promis
result
support
protect
therapeut
use
vaccin
tcell
epitop
import
cytolyt
regulatori
respons
pathogen
necessari
element
vaccin
ration
select
protein
antigen
sequenc
function
tcell
epitop
vaccin
formul
therefor
crucial
success
applic
vaccin
strategi
select
pathogen
antigen
sequenc
includ
epitopebas
vaccin
must
address
sever
determin
issu
goal
identifi
relev
tcell
epitop
hla
class
ii
effect
suffici
vaccin
protect
pathogen
challeng
major
question
degre
protect
achiev
without
concomit
administr
neutral
antibodi
epitop
vaccin
must
also
protect
broad
spectrum
human
popul
wide
varieti
pathogen
strain
possibl
present
challeng
mani
pathogen
exhibit
high
mutat
rate
select
new
genet
variant
resist
exist
immun
respons
earlier
pathogen
subtyp
may
subvert
immun
respons
alter
peptid
ligand
phenomena
therefor
import
choos
epitop
deriv
conserv
peptid
sequenc
also
extrem
polymorph
character
human
leukocyt
antigen
hla
restrict
proport
human
popul
respond
particular
antigen
thu
advantag
select
promiscu
tcell
epitop
bind
sever
allel
hla
supertyp
maxim
popul
coverag
focu
bioinformaticsbas
approach
mean
enhanc
optim
select
potenti
target
immun
respons
valid
experi
test
biolog
function
antigen
sequenc
immunesystem
base
assay
report
describ
combin
immunoinformat
molecular
strategi
vaccin
develop
base
upon
grow
number
bioinformat
tool
antigen
sequenc
avail
public
databas
identifi
pathogen
peptid
silico
predict
tcell
epitop
greatli
reduc
list
candid
epitop
shortlist
start
point
molecular
experi
valid
vaccin
target
base
biolog
function
select
antigen
sequenc
predict
futur
mutat
deriv
past
evolutionari
histori
therefor
import
collect
sequenc
repres
possibl
genet
variant
pathogen
extend
period
time
broad
geograph
rang
ideal
avail
protein
sequenc
pertain
pathogen
collect
major
public
databas
ncbi
entrez
protein
databas
wwwncbinlmnihgoventrez
sinc
public
databas
often
contain
error
discrep
duplic
entri
data
clean
process
need
correct
anomali
exampl
annot
error
discrep
dengu
viru
record
identifi
correct
prior
analysi
sever
method
avail
found
abk
structur
rulebas
approach
well
suit
type
task
allow
fulli
annot
set
influenza
protein
sequenc
clean
independ
verifi
two
week
identif
conserv
sequenc
initi
step
overcom
pathogen
genom
variat
case
extens
hiv
influenza
virus
dengu
virus
multipl
sequenc
align
pathogen
protein
examin
consensussequ
base
approach
select
sequenc
conserv
larg
major
variant
pathogen
multipl
group
clade
serotyp
subtyp
pangroup
consensu
sequenc
obtain
align
consensu
sequenc
deriv
differ
group
fig
rather
analyz
pangroup
align
combin
sequenc
group
prevent
overrepres
group
bias
deriv
consensu
sequenc
identif
conserv
align
site
base
represent
frequenc
consensu
residu
among
sequenc
align
depend
variabl
exhibit
differ
pathogen
group
cutoff
intragroup
represent
conserv
sequenc
may
set
exampl
dengu
viru
analysi
select
conserv
site
common
across
four
serotyp
exhibit
least
represent
four
serotyp
fig
immunolog
applic
minimum
conserv
sequenc
length
nine
amino
acid
requir
repres
typic
length
peptid
bind
hla
molecul
consensusbas
method
consid
align
site
independ
howev
vaccin
target
short
peptid
typic
whose
combinatori
composit
produc
great
divers
even
adjac
site
highli
conserv
residu
robust
method
base
inform
entropi
measur
degre
variabl
peptid
length
infer
evolutionari
stabil
entropi
h
repres
variabl
nonam
peptid
center
given
align
site
comput
probabl
p
nonam
peptid
occur
site
peptid
center
given
posit
partial
overlap
peptid
center
neighbour
posit
low
entropi
character
stabl
peptid
entropi
valu
indic
conserv
nonam
entropi
rise
increas
variabl
site
affect
number
variant
site
also
respect
frequenc
abkavana
antigen
variabl
analyz
tool
om
et
al
manuscript
prepar
perform
peptid
entropi
analysi
fig
show
intraand
panserotyp
peptid
entropi
plot
dengu
viru
protein
data
show
four
serotyp
distinct
pattern
highli
conserv
variabl
region
thu
panserotyp
low
entropi
region
restrict
discret
short
region
correspond
conserv
sequenc
select
consensussequ
method
gener
recogn
conserv
protein
sequenc
repres
import
function
domain
mutat
would
detriment
surviv
pathogen
function
conserv
sequenc
elucid
databas
compris
data
protein
famili
domain
function
site
pfam
databas
wwwsangeracuk
softwarepfam
map
locat
conserv
sequenc
structur
protein
may
also
provid
relev
inform
fig
mani
structur
avail
pdb
databas
wwwpdborg
potenti
vaccin
target
analyz
specif
target
pathogen
vaccin
design
epitop
common
pathogen
could
either
use
induc
crossprotect
detriment
induc
alteredligand
effect
identifi
conserv
sequenc
therefor
submit
blast
search
protein
sequenc
ncbi
exclud
target
pathogen
sequenc
found
pathogen
extent
represent
analyz
exampl
mani
dengu
viru
conserv
sequenc
found
wide
present
flavivirus
algorithm
predict
hla
bind
peptidesded
algorithm
base
distinct
predict
model
use
locat
put
promiscu
tcell
epitop
hla
class
ii
supertyp
within
conserv
sequenc
comput
epitop
predict
system
netctl
wwwcbsdtudkservicesnetctl
multipr
tepitop
proven
effect
accur
map
tcell
epitop
select
peptid
experiment
valid
put
epitop
predict
multipl
model
chosen
sinc
consensu
predict
combin
model
shown
accur
individu
model
predict
addit
promiscu
respect
multipl
allel
hla
supertyp
put
tcell
epitop
exhibit
multiplesupertyp
promiscu
addit
form
promiscu
observ
sever
virus
dengu
hiv
tcell
epitop
specif
multipl
hla
supertyp
advantag
vaccin
design
effect
increas
number
epitop
individu
respond
provid
much
extens
coverag
popul
promiscu
tcell
epitop
may
local
cluster
report
studi
outer
membran
chlamydia
trachomati
among
other
cluster
also
ideal
develop
epitopebas
vaccin
contain
multipl
promiscu
epitop
multipr
use
predict
immunolog
hotspot
percentag
individu
popul
predict
respond
put
conserv
promiscu
tcell
epitop
predict
popul
coverag
analysi
tool
immun
epitop
databas
wwwimmuneepitopeorgtoolspopul
tool
provid
allel
frequenc
popul
group
differ
geograph
area
genotyp
differ
primari
secondari
pathogen
vaccin
challeng
infect
constitut
critic
consider
protect
case
patholog
immun
intraand
intergroup
sequenc
variabl
tcell
epitop
sequenc
may
contain
singl
multipl
amino
acid
differ
within
group
variant
put
promiscu
tcell
epitop
identifi
among
report
sequenc
pathogen
group
represent
within
group
across
group
observ
variant
put
epitop
given
align
posit
compris
nonam
site
possess
least
one
amino
acid
differ
put
epitop
low
variant
represent
conserv
potenti
advantag
avoid
alter
peptid
ligand
predict
tcell
epitop
conserv
sequenc
mani
case
conform
commonli
without
identif
specif
allel
howev
report
experiment
confirm
tcell
epitop
therefor
search
extant
literatur
immun
epitop
databas
wwwimmuneepitopeorg
perform
report
human
tcell
epitop
class
ii
fulli
partial
overlap
identifi
conserv
sequenc
exampl
eight
report
human
tcell
epitop
dengu
viru
correspond
predict
promiscu
tcell
epitop
conserv
sequenc
tabl
measur
valid
comput
predict
necessari
accur
interpret
result
measur
current
includ
hla
bind
assay
immun
hla
transgen
mice
elispot
assay
peptidespecif
tcell
activ
pathogen
infect
human
subject
perform
function
assess
dengu
viru
conserv
sequenc
four
predict
contain
hladr
epitop
three
four
confirm
elispot
assay
tcell
activ
peptid
close
mimic
conserv
sequenc
tabl
addit
two
also
elispot
posit
predict
bind
dr
molecul
summari
seven
conserv
sequenc
five
contain
hladr
tcell
epitop
least
three
promiscu
multipl
hladr
allel
predict
model
help
select
antigen
sequenc
addit
studi
immun
respons
especi
sequenc
predict
multipl
algorithm
bioinformat
approach
present
paper
prove
gener
success
appli
sever
virus
dengu
viru
thu
approach
use
templat
analysi
pathogen
provid
novel
gener
approach
formul
epitopebas
vaccin
effect
broad
divers
pathogen
applic
human
popul
larg
new
methodolog
enabl
systemat
screen
pathogen
data
would
otherwis
imposs
carri
experiment
due
mani
pathogen
sequenc
high
viral
divers
variat
immun
system
among
individu
extens
polymorph
hla
therefor
significantli
reduc
effort
cost
experiment
provid
systemat
screen
step
involv
determin
sequenc
fragment
conserv
across
four
serotyp
protein
use
consensussequencebas
approach
consensu
sequenc
protein
deriv
serotyp
respect
multipl
sequenc
align
residu
consensu
sequenc
repres
predomin
residu
posit
correspond
multipl
sequenc
align
b
four
consensu
sequenc
protein
one
serotyp
align
reveal
sequenc
fragment
least
nine
amino
acid
long
ident
across
four
consensu
sequenc
dengu
panserotyp
conserv
sequenc
protein
intraserotyp
percentag
represent
conserv
amino
acid
posit
number
accord
align
sequenc
dengu
protein
four
serotyp
peptid
entropi
plot
intraand
panserotyp
align
dengu
viru
dv
protein
intraserotyp
panserotyp
dv
averag
peptid
entropi
valu
posit
base
frequenc
nonam
peptid
variant
present
posit
protein
align
identifi
panserotyp
conserv
sequenc
protein
found
local
panserotyp
conserv
antigen
region
protein
valu
rang
indic
high
probabl
sequenc
remain
conserv
futur
molecular
locat
dengu
panserotyp
conserv
sequenc
glygngvvt
ltimdlhpg
protein
structur
major
portion
glygngvvt
conserv
sequenc
red
local
buri
region
structur
b
ltimdlhpg
conserv
sequenc
red
local
expos
region
structur
suggest
conserv
sequenc
glygngvvt
less
like
mutat
compar
ltimdlhpg
though
share
ident
level
intraserotyp
percentag
represent
